3719 Results

People

  1. Hudis
    Hudis
  2. Lee
    Lee
  3. Giralt
    Giralt
  4. Motzer
    Motzer
  5. Barakat
    Barakat
  6. Scher
    Scher
  7. Ladanyi
    Ladanyi
  8. Levine
    Levine
  9. Chi
    Chi
  10. DeMatteo
    DeMatteo

Groups

  1. Department of Medicine (1284)
  2. Surgery (899)
  3. GSK Faculty (811)
  4. Solid Tumor Oncology Division (708)
  5. Survivorship Research (632)
  6. Sloan Kettering Institute Faculty (579)
  7. Center for Hematologic Malignancies (503)
  8. Department of Pathology and Laboratory Medicine (470)
  9. Population Sciences Research Program (431)
  10. Epidemiology and Biostatistics (426)
  1. "2012"
Formats
  1. Journal Article (2365)
  2. Meeting Abstract (1182)
  3. Book Section (137)
  4. Conference Paper (23)
  5. Book Whole (10)
  6. Correspondence (1)
  7. Editorial (1)
Groups
  1. Department of Medicine (1284)
  2. Surgery (899)
  3. GSK Faculty (811)
  4. Solid Tumor Oncology Division (708)
  5. Survivorship Research (632)
  6. Sloan Kettering Institute Faculty (579)

More Groups

People
  1. Clifford Hudis (64)
  2. Nancy Lee (64)
  3. Sergio Giralt (59)
  4. Robert Motzer (57)
  5. Richard Barakat (54)
  6. Howard Scher (53)

More People

Years
  1. 2012 (3719)
Publications
  1. Journal of Clinical Oncology (315)
  2. Blood (152)
  3. International Journal of Radiation Oncology, Biology, Physics (125)
  4. Cancer Research (110)
  5. Modern Pathology (80)
  6. Gynecologic Oncology (76)

More Publications

Publishers
  1. Elsevier Inc. (519)
  2. American Society of Clinical Oncology (337)
  3. Springer (239)
  4. Nature Publishing Group (202)
  5. Wiley Blackwell (193)
  6. American Association for Cancer Research (192)

More Publishers

Results (3719)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Updated overall survival (OS) results for BRIM-3, a phase III randomized, open-label, multicenter trial comparing BRAF inhibitor vemurafenib (vem) with dacarbazine (DTIC) in previously untreated patients with BRAF(V600E)-mutated melanoma
    Meeting Abstract

    Chapman, P. B.; Hauschild, A.; Robert, C.; Larkin, J. M. G.; Haanen, J. B. A. G.; Ribas, A.; Hogg, D.; Hamid, O.; Ascierto, P. A.; Testori, A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Breast MRI in elderly patients with breast cancer: Does breast density matter?
    Meeting Abstract

    Casher, J.; Stempel, M.; Eaton, A.; Morris, E. A.; Gemignani, M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Longitudinal changes in health care utilization by adult survivors of childhood cancer in the Childhood Cancer Survivor Study (CCSS)
    Meeting Abstract

    Casillas, J. N.; Liu, Q.; Hudson, M. M.; Greenberg, M.; Yeazel, M. W.; Ness, K. K.; Robison, L. L.; Armstrong, G. T.; Leisenring, W. M.; Yasui, Y.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Characterizing fatigue associated with sunitinib (SU) in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Cella, D.; Davis, M. P.; Bushmakin, A. G.; Cappelleri, J. C.; Hahn, E. A.; Korytowsky, B.; Bhattacharyya, H.; Sandin, R.; Beaumont, J. L.; Matczak, E.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer
    Meeting Abstract

    Cercek, A.; Siegel, C.; Reidy, D. L.; Saltz, L.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Randomized phase III, multicenter, open-label study comparing TH-302 in combination with doxorubicin versus doxorubicin alone in subjects with locally advanced unresectable or metastatic soft tissue sarcoma
    Meeting Abstract

    Chawla, S. P.; Reinke, D. K.; Saks, S.; Kroll, S.; Tap, W. D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Quantitating pathologic response to neoadjuvant chemotherapy in KRAS-mutated versus nonmutated lung cancers
    Meeting Abstract

    Chaft, J. E.; Paik, P. K.; Sima, C. S.; Kris, M. G.; Krug, L. M.; Azzoli, C. G.; Riely, G. J.; Pietanza, M. C.; Rusch, V. W.; Travis, W. D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Risk of skin rash with the proteasome inhibitor bortezomib: Updated systematic review and meta-analysis
    Meeting Abstract

    Case, E. C.; Wu, S.; Gerecitano, J. F.; Lacouture, M. E.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Randomized multicenter double-blind phase II trial: The immunological adjuvant OPT-821 with or without a trivalent ganglioside vaccine in metastatic sarcoma patients following metastasectomy
    Meeting Abstract

    Carvajal, R. D.; Chugh, R.; Milhem, M. M.; Ryan, C. W.; George, S.; Chmielowski, B.; Agulnik, M.; Rodler, E. T.; Elias, A. D.; Budd, G. T.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Pharmacodynamic activity of selumetinib to predict radiographic response in advanced uveal melanoma
    Meeting Abstract

    Carvajal, R. D.; Ambrosini, G.; Wolchok, J. D.; Chapman, P. B.; Dickson, M. A.; D'Angelo, S. P.; Bluth, M. J.; Paucar, D.; Fusco, A.; Bohr, D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save